1 |
van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome. Lancet Neurol 2008;7:939-50.
DOI
|
2 |
Moulin DE, Hagen N, Feasby TE, Amireh R, Hahn A. Pain in Guillain-Barre syndrome. Neurology 1997;48:328-31.
DOI
|
3 |
Asahina M, Kuwabara S, Suzuki A, Hattori T. Autonomic function in demyelinating and axonal subtypes of Guillain-Barre syndrome. Acta Neurol Scand 2002;105:44-50.
DOI
|
4 |
Hasser EM, Moffitt JA. Regulation of sympathetic nervous system function after cardiovascular deconditioning. Ann N Y Acad Sci 2001;940:454-68.
|
5 |
Kloesel B, Hickson LJ. Severe hyponatremia as the initial sign preceding guillain-barre syndrome, an acute inflammatory demyelinating polyneuropathy: a case report. Case Rep Neurol Med 2013;2013:923602.
|
6 |
Saifudheen K, Jose J, Gafoor VA, Musthafa M. Guillain-Barre syndrome and SIADH. Neurology 2011;76:701-4.
DOI
|
7 |
Hoffmann O, Reuter U, Schielke E, Weber JR. SIADH as the first symptom of Guillain-Barre syndrome. Neurology 1999;53:1365.
|
8 |
Ramanathan S, McMeniman J, Cabela R, Holmes-Walker DJ, Fung VS. SIADH and dysautonomia as the initial presentation of Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 2012;83:344-5.
DOI
|
9 |
Singh NK, Jaiswal AK, Misra S, Srivastava PK. Assessment of autonomic dysfunction in Guillain-Barre syndrome and its prognostic implications. Acta Neurol Scand 1987;75:101-5.
DOI
|
10 |
Burns TM, Lawn ND, Low PA, Camilleri M, Wijdicks EF. Adynamic ileus in severe Guillain-Barre syndrome. Muscle Nerve 2001;24:963-5.
DOI
|
11 |
Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore) 1969;48:173-215.
|
12 |
de Jager AE, Sluiter HJ. Clinical signs in severe Guillain-Barre syndrome: analysis of 63 patients. J Neurol Sci 1991;104:143-50.
DOI
|
13 |
Drossman DA. Rome III: the new criteria. Chin J Dig Dis 2006;7:181-5.
DOI
|
14 |
Flachenecker P, Wermuth P, Hartung HP, Reiners K. Quantitative assessment of cardiovascular autonomic function in Guillain-Barre syndrome. Ann Neurol 1997;42:171-9.
DOI
|
15 |
Dimario FJ Jr, Edwards C. Autonomic dysfunction in childhood Guillain-Barre syndrome. J Child Neurol 2012;27:581-6.
DOI
|
16 |
Hund EF, Borel CO, Cornblath DR, Hanley DF, McKhann GM. Intensive management and treatment of severe Guillain-Barre syndrome. Crit Care Med 1993;21:433-46.
DOI
|
17 |
Turchetti A, Guglielmi S, Fossati C, Matrunola M, Corrado G. Gastric emptying time in cyclic vomiting syndrome in children. Eur Rev Med Pharmacol Sci 2004;8:295-8.
|
18 |
Sim YJ, Kim JM, Kwon S, Choe BH. Clinical experience with amitriptyline for management of children with cyclic vomiting syndrome. Korean J Pediatr 2009;52:538-43.
DOI
|
19 |
Prakash C, Clouse RE. Cyclic vomiting syndrome in adults: clinical features and response to tricyclic antidepressants. Am J Gastroenterol 1999;94:2855-60.
DOI
|
20 |
Yang HR, Ko JS, Seo JK. A study on the disease course and prognosis of cyclic vomiting syndrome. J Korean Pediatr Soc 2001;44:1141-56.
|